FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965564005> ?p ?o ?g. }

• W1965564005 endingPage "617" @default.
• W1965564005 startingPage "609" @default.
• W1965564005 abstract "Objectives: This pilot study evaluated the efficacy and safety of adjunctive topiramate compared with placebo in the treatment of patients with a diagnosis of schizoaffective disorder, bipolar type (SAD‐BT). Methods: A sample of 48 adult patients with a Diagnostic and Statistical Manual of Mental Disorders , 4th Edition , Text Revision (DSM‐IV‐TR) diagnosis of SAD‐BT (supported by the Structured Clinical Interview for DSM‐IV Axis I Disorder , Patient Edition ) were randomly assigned in a 2:1 ratio (favoring topiramate) to 8 weeks of double‐blind treatment with topiramate (100–400 mg/day) or placebo. Patients who had achieved a ≥20% decrease from baseline in their Positive and Negative Syndrome Scale (PANSS) total scores were given the opportunity to continue for an additional 8 weeks of double‐blind treatment. The dosage of the study medicine was continued unchanged from the earlier 8‐week study period. At the end of the study period, the study medicine was tapered and discontinued over a 2‐week period. Primary efficacy was assessed at 8 weeks using the mean change between treatment groups of the PANSS total scores in the intent‐to‐treat population of randomized patients. Several secondary measures were also assessed. Safety analyses included monitoring of adverse events, vital signs, electrocardiogram (ECG) and laboratory values. Results: Even though both treatments reduced scores on various psychopathology rating scales, adjunctive topiramate treatment (nearly 275 mg/day) did not show increased efficacy relative to placebo on the primary outcome measure (PANSS scale) or any of the secondary outcome measures. Topiramate‐treated patients lost significantly more body weight than placebo‐treated patients, which led to a significant reduction in body mass index (BMI). Relative to adjunctive placebo, topiramate‐treated patients experienced higher rates of paresthesia, sedation, word‐finding difficulty, sleepiness, and forgetfulness, but these differences were not statistically significant. There were no clinically significant abnormalities in either the ECG or laboratory results. There were no serious adverse events in the study. Further, there was no worsening of the PANSS total scores (to ≥10% from baseline), and no significant differences between the treatments on worsening of total Montgomery–Asberg Depression Rating Scale (MADRS) scores [1/13 (7.7%) for placebo; 1/25 (4.0%) for topiramate]. Conclusions: This pilot study did not support clinical efficacy for adjunctive topiramate treatment in patients with SAD‐BT. There were no major safety or tolerability issues in this study. Confirming the results of other studies, topiramate‐treated patients did experience greater body weight loss and reduction in BMI." @default.
• W1965564005 created "2016-06-24" @default.
• W1965564005 creator A5003924339 @default.
• W1965564005 creator A5010089227 @default.
• W1965564005 creator A5019021504 @default.
• W1965564005 creator A5037135804 @default.
• W1965564005 creator A5039844117 @default.
• W1965564005 creator A5067826976 @default.
• W1965564005 creator A5072882426 @default.
• W1965564005 creator A5081105512 @default.
• W1965564005 creator A5085436790 @default.
• W1965564005 creator A5090521815 @default.
• W1965564005 date "2007-09-01" @default.
• W1965564005 modified "2023-10-10" @default.
• W1965564005 title "A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type" @default.
• W1965564005 cites W1963650892 @default.
• W1965564005 cites W1964800048 @default.
• W1965564005 cites W1970908493 @default.
• W1965564005 cites W1980235427 @default.
• W1965564005 cites W1983377547 @default.
• W1965564005 cites W1984421363 @default.
• W1965564005 cites W1999689270 @default.
• W1965564005 cites W2003629147 @default.
• W1965564005 cites W2010402674 @default.
• W1965564005 cites W2044738289 @default.
• W1965564005 cites W2048002593 @default.
• W1965564005 cites W2063347068 @default.
• W1965564005 cites W2064119051 @default.
• W1965564005 cites W2073740255 @default.
• W1965564005 cites W2090784587 @default.
• W1965564005 cites W2116246373 @default.
• W1965564005 cites W2125738714 @default.
• W1965564005 cites W2128746746 @default.
• W1965564005 cites W2131823335 @default.
• W1965564005 cites W2140606211 @default.
• W1965564005 cites W2165379748 @default.
• W1965564005 cites W2167659819 @default.
• W1965564005 doi "https://doi.org/10.1111/j.1399-5618.2007.00506.x" @default.
• W1965564005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17845276" @default.
• W1965564005 hasPublicationYear "2007" @default.
• W1965564005 type Work @default.
• W1965564005 sameAs 1965564005 @default.
• W1965564005 citedByCount "29" @default.
• W1965564005 countsByYear W19655640052012 @default.
• W1965564005 countsByYear W19655640052013 @default.
• W1965564005 countsByYear W19655640052015 @default.
• W1965564005 countsByYear W19655640052016 @default.
• W1965564005 countsByYear W19655640052018 @default.
• W1965564005 countsByYear W19655640052019 @default.
• W1965564005 countsByYear W19655640052021 @default.
• W1965564005 countsByYear W19655640052023 @default.
• W1965564005 crossrefType "journal-article" @default.
• W1965564005 hasAuthorship W1965564005A5003924339 @default.
• W1965564005 hasAuthorship W1965564005A5010089227 @default.
• W1965564005 hasAuthorship W1965564005A5019021504 @default.
• W1965564005 hasAuthorship W1965564005A5037135804 @default.
• W1965564005 hasAuthorship W1965564005A5039844117 @default.
• W1965564005 hasAuthorship W1965564005A5067826976 @default.
• W1965564005 hasAuthorship W1965564005A5072882426 @default.
• W1965564005 hasAuthorship W1965564005A5081105512 @default.
• W1965564005 hasAuthorship W1965564005A5085436790 @default.
• W1965564005 hasAuthorship W1965564005A5090521815 @default.
• W1965564005 hasConcept C118552586 @default.
• W1965564005 hasConcept C123273963 @default.
• W1965564005 hasConcept C126322002 @default.
• W1965564005 hasConcept C142724271 @default.
• W1965564005 hasConcept C15744967 @default.
• W1965564005 hasConcept C168563851 @default.
• W1965564005 hasConcept C197934379 @default.
• W1965564005 hasConcept C204787440 @default.
• W1965564005 hasConcept C27081682 @default.
• W1965564005 hasConcept C2776174506 @default.
• W1965564005 hasConcept C2777683783 @default.
• W1965564005 hasConcept C2778186239 @default.
• W1965564005 hasConcept C2779727114 @default.
• W1965564005 hasConcept C2780135775 @default.
• W1965564005 hasConcept C2780325297 @default.
• W1965564005 hasConcept C2780733359 @default.
• W1965564005 hasConcept C2908647359 @default.
• W1965564005 hasConcept C3018162438 @default.
• W1965564005 hasConcept C71924100 @default.
• W1965564005 hasConcept C99454951 @default.
• W1965564005 hasConceptScore W1965564005C118552586 @default.
• W1965564005 hasConceptScore W1965564005C123273963 @default.
• W1965564005 hasConceptScore W1965564005C126322002 @default.
• W1965564005 hasConceptScore W1965564005C142724271 @default.
• W1965564005 hasConceptScore W1965564005C15744967 @default.
• W1965564005 hasConceptScore W1965564005C168563851 @default.
• W1965564005 hasConceptScore W1965564005C197934379 @default.
• W1965564005 hasConceptScore W1965564005C204787440 @default.
• W1965564005 hasConceptScore W1965564005C27081682 @default.
• W1965564005 hasConceptScore W1965564005C2776174506 @default.
• W1965564005 hasConceptScore W1965564005C2777683783 @default.
• W1965564005 hasConceptScore W1965564005C2778186239 @default.
• W1965564005 hasConceptScore W1965564005C2779727114 @default.
• W1965564005 hasConceptScore W1965564005C2780135775 @default.
• W1965564005 hasConceptScore W1965564005C2780325297 @default.
• W1965564005 hasConceptScore W1965564005C2780733359 @default.

• next